Current role
Dr. Marc Van Dijk
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Marc Van Dijk
MiNK Therapeutics, Inc. reported in an 8-K filed October 18, 2024 that Dr. Marc Van Dijk was appointed Scientific Advisory Board Member and Strategic Consultant, effective November 15, 2024.
“On October 15, 2024, MiNK Therapeutics, Inc. (the "Company") acknowledged that Dr. Marc Van Dijk will transition from his role as Chief Scientific Officer and assume the positions of Scientific Advisory Board Member and Strategic Consultant.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
MiNK Therapeutics, Inc. (INKT)
SEC 8-K
Current2024-11-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MiNK Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Melissa Orilall CFO
- Austin Charette Chief Accounting Officer
- Dr. John Holcomb Board Member
- Jennifer Buell Board Member
- John Holcomb Board Member
- Peter Behner Board Member
- Robert Kadlec Board Member
- Ulf Wiinberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.